"La Clinique accueille plus de 65 000 patients par an sur différentes spécialités : Médecine, Chirurgie, Oncologie, Réanimation Adulte, Soins Intensifs de Cardiologie, Soins Intensifs de Neurologie, Néphrologie et Dialyse, Hépato-Gastro-Entérologie"

During the past decade, Clinique Claude Bernard conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 1 clinical trials were completed, i.e. on average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Claude Bernard" #1 sponsor was "UNICANCER" with 8 trials, followed by "Institut Claudius Regaud" with 5 trials sponsored, "Center Eugene Marquis" with 3 trials sponsored, "Intergroupe Francophone de Cancerologie Thoracique" with 3 trials sponsored and "Centre Francois Baclesse" with 3 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Claude Bernard" #1 collaborator was "Sanofi" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "CENTRE HOSPITALIER COMMINGES PYRENEES" with 1 trials as a collaborator, "Centre Hospitalier Ales" with 1 trials as a collaborator and "Centre Hospitalier Intercommunal de Castres" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Claude Bernard" are "Breast Cancer" (4 trials), "Prostate Cancer" (4 trials), "Metastatic Colorectal Cancer" (2 trials), "Oropharynx Cancer" (2 trials) and "ALK Gene Mutation" (1 trials). Many other conditions were trialed in "Clinique Claude Bernard" in a lesser frequency.

Most popular intervention types in "Clinique Claude Bernard" are "Drug" (12 trials), "Radiation" (10 trials), "Other" (8 trials), "Device" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (3 trials), "epirubicin hydrochloride" (3 trials), "fluorouracil" (3 trials), "Docetaxel" (2 trials) and "Experimental arm" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Claude Bernard" are 19 trials for "All" genders, 6 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Clinique Claude Bernard". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Clinique Claude Bernard, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Claude Bernard, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".

Clinique Claude Bernard has several departments that took part in Clinical trials: "Clinique Claude Bernard; Onco Hematologie" - 3 trials